Breaking News Instant updates and real-time market news.

BABA

Alibaba

$171.22

-1.745 (-1.01%)

, SFTBF

SoftBank

$0.00

(0.00%)

05:59
10/15/19
10/15
05:59
10/15/19
05:59

Paytm close to raising $2B funding from Ant Financial, SoftBank, Bloomberg says

Paytm is close to raising $2B in funding from Ant Financial (BABA) and SoftBank (SFTBF), at a valuation of $16B, Bloomberg's Saritha Rai reports, citing a person familiar with the matter. Rob Citrone's Discovery Capital Management is also in discussions to join the funding round, which will help Paytm fend off competition from newer entrants into the space, including Facebook (FB), Google (GOOGL) and Walmart (WMT)-owned Flipkart's PhonePe, the person says. Reference Link

BABA

Alibaba

$171.22

-1.745 (-1.01%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

FB

Facebook

$183.29

-0.91 (-0.49%)

GOOGL

Alphabet Class A

$1,217.61

2.99 (0.25%)

GOOG

Alphabet

$1,218.23

4.37 (0.36%)

WMT

Walmart

$119.12

-1.12 (-0.93%)

  • 16

    Oct

  • 23

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

  • 19

    Nov

BABA Alibaba
$171.22

-1.745 (-1.01%)

10/04/19
HSBC
10/04/19
NO CHANGE
Target $233
HSBC
Buy
HSBC boosts Alibaba target to $233 on continued dominance in retail market
After hosting a dinner with an apparel brand expert, HSBC analyst Binnie Wong says Alibaba (BABA) "remains dominant." Alibaba is still leading the way in the brands' online retail market, Wong tells investors in a research note. Further, Tmall is more effective in new products launches, with higher profits for Alibaba versus Pinduoduo (PDD), contends the analyst. Wong views Alibaba as attractively valued and boosted the stock's price target to $233 from $230. The analyst keeps a Buy rating on the shares.
09/16/19
SBSH
09/16/19
NO CHANGE
Target $233
SBSH
Buy
Alibaba unlikely to revise sales guidance at investor day, says Citi
Citi analyst Alicia Yap expects Alibaba's September 23 and 24 investor days to focus on new chairman and CEO Daniel Zhang's vision and strategy, the CFO's comments on investment strategy and margins, and progress and customer feedback on recommended feeds and Tmall 2.0 initiatives. The analyst believes the CFO is unlikely to revise Alibaba's fiscal 2020 revenue guidance, and instead will likely offer reassurance on "healthy" growth in core marketplace margins and on a disciplined approach to new investment initiatives. Yap keeps a Buy rating on Alibaba shares with a $233 price target.
09/10/19
BOFA
09/10/19
NO CHANGE
Target $39
BOFA
Buy
Easing competition presents potential upside for Pinduoduo, says BofA/Merrill
BofA Merrill Lynch analyst Joyce Ju said her proprietary price point checks on some products across Chinese e-commerce platforms, including Alibaba's (BABA) Taobao, support the assumption of a stabilized competitive landscape and less aggressive promotion in Q3. The easing price competition should give Pinduoduo (PDD) more budget flexibility and room for moderate margin upside in non-peak season, according to Ju, who raised her price target on the stock to $39 from $34. She maintains a Buy rating on Pinduoduo.
09/06/19
SBSH
09/06/19
NO CHANGE
Target $326
SBSH
Buy
NetEase price target raised to $326 from $301 at Citi
Citi analyst Hillman Chan raised his price target for NetEase (NTES) to $326 from $301 saying he's positive on the sale of Kaola to Alibaba (BABA). The disposal signals NetEase's continuous focus on profitability and the additional funding to Cloud Music could make it more competitive versus Tencent Music (TME), Chan tells investors in a research note. The analyst expects investors to gradually assign value to NetEase's remaining non-gaming assets, like Cloud Music, and he keeps a Buy rating on the shares.
SFTBF SoftBank
$0.00

(0.00%)

12/12/18
RBCM
12/12/18
NO CHANGE
Target $230
RBCM
Outperform
Nvidia price target lowered to $230 from $260 at RBC Capital
RBC Capital analyst Mitch Steves lowered his price target on Nvidia (NVDA) to $230 after yesterday's report that Softbank (SFTBF) is exploring the sale of its stake in the company early next year. The analyst believes that in the near-term, the speculation is a negative since Softbank has "solid information on overall Data Center trends". Steves maintains his Outperform rating however, stating that a number of long-only investment managers have not participated in the run-up of the stock price. The analyst adds that Nvidia's long-term investment story around "AI/VR/AR/Autonomous" driving remains intact.
02/28/19
BTIG
02/28/19
NO CHANGE
Target $60
BTIG
Buy
SoftBank price target raised to $60 from $50 at BTIG
BTIG analyst Walter Piecyk raised his price target on SoftBank (SFTBY) to $60 and kept his Buy rating, citing his "better understanding" of the previously acquired ARM Holdings business which warrants a higher multiple. The analyst also sees a major catalyst coming in the "imminent decision" around Sprint (S) / T-Mobile (TMUS) deal, which could amount to additional $14 price target impact on Softbank shares.
SFTBY SoftBank
$0.00

(0.00%)

07/08/19
WBLR
07/08/19
NO CHANGE
WBLR
Outperform
AeroVironment can take 'material' share in $15B market, says William Blair
AeroVironment (AVAV) can take "material" market share from the $15B per year satellite manufacturing industry as a supplier to Softbank (SFTBY), William Blair analyst Louie DiPalma tells investors in a research note after meeting with the head of Softbank's Advanced Technology Division, Ryuji Wakikawa. The analyst points out that Softbank in January 2018 formed a joint venture with AeroVironment called HAPSMobile to develop high-altitude, solar-powered drones for the purpose of providing next-generation Internet of Things connectivity. HAPSMobile now represents nearly 20% of AeroVironment's sales, DiPalma says. He affirms an Outperform rating on AeroVironment shares.
FB Facebook
$183.29

-0.91 (-0.49%)

10/07/19
DBAB
10/07/19
UPGRADE
Target $91
DBAB
Buy
Deutsche upgrades Match Group to Buy on 'untarnished' fundamentals
Deutsche Bank analyst Kunal Madhukar upgraded Match Group (MTCH) to Buy from Hold with a price target of $91, down from $93. Despite a "strong" quarter and guidance raise, Match shares have been sinking since the company reported Q2 results, Madhukar tells investors in a research note. The analyst, while admitting there is potential for near-term trading dislocation and the specter of increased supply once IAC (IAC) decides to spin off Match, believes the stock has overacted to the downside from the launch of Facebook (FB) Dating and the Federal Trade Commission lawsuit against Match.com. Match Group's business fundamentals "remain untarnished," and if anything, are stronger after Tinder began offering consumers more payment choice on Android, Madhukar contends. Nomura Instinet this morning also upgraded Match Group. The stock in premarket trading is up 4%, or $3.17, to $77.60.
09/30/19
JEFF
09/30/19
NO CHANGE
JEFF
Jefferies incrementally positive on Trade Desk, Snap after Ad Week
Coming out of the Ad Week conference, Jefferies analyst Brent Thill continues to favor Facebook (FB) and Alphabet (GOOGL) in digital advertising, but the analyst is also incrementally positive on Trade Desk (TTD) and Snap (SNAP). Trade Desk is a direct beneficiary of the shift to emerging ad formats like connected TV and podcasts, which are "highly engaging and still relatively untapped," Thill tells investors in a research note. And while Instagram Stories remains the best format to reach younger users, Snap and Tik Tok are gaining traction and were among the most widely attended sessions, adds the analyst. In addition, Thill was surprised that Amazon.com (AMZN) did not have much presence at the conference.
10/09/19
DBAB
10/09/19
NO CHANGE
Target $230
DBAB
Buy
Facebook estimates and price target lowered at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley expects "solid" Q3 results from Facebook, but sees consensus estimates "migrating lower" following the print on early 2020 operating expenditure guidance. Once the reset occurs, the story looks good for 2020, with Instagram Checkout set to expand in participants and add features, ramping monetization in the Instagram Explore, and continued resurgence in core Facebook ad spend, Walmsley tells investors in a pre-earnings research note. He lowered his 2020 earnings per share estimate for Facebook to $9.45 from $9.81, and price target for $230 from $235, while keeping a Buy rating on the shares.
10/10/19
10/10/19
UPGRADE
Target $89

Outperform
Match Group upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Jason Helfstein upgraded Match Group (MTCH) to Outperform from Perform, with a price target of $89. The analyst notes that the stock is down 27% from its highs on an overall correction in momentum names, confusion surrounding a likely debt transfer as part ofthe spinoff from IAC (IAC) and concerns over the FTC lawsuit. Helfstein is now less concerned about competition from Facebook (FB) Dating, and highlights that 3P download data shows an acceleration in Tinder and localized offerings. Lastly, his survey work indicates that only 44% of U.S. singles are currently using an online dating product, suggesting material growth in overall usage.
GOOGL Alphabet Class A
$1,217.61

2.99 (0.25%)

10/08/19
OPCO
10/08/19
NO CHANGE
Target $410
OPCO
Outperform
Oppenheimer cautiously in line with consensus estimates, guidance for Netflix
After looking at 3P data from SimilarWeb, Google (GOOGL) Search Trends and YouTube Trailer views, Oppenheimer analyst Jason Helfstein notes that data points to mixed results for Netflix (NFLX). While SimilarWeb data suggests a Q3 subscriber miss, Google Trends and YouTube data are more favorable, he adds. Overall, the analyst believes the Street estimates have remained in line with guidance as uncertainty over data interpretation has led to an overhang, and says he remains cautiously in line with consensus estimates and guidance. Helfstein has an Outperform rating and $410 price target on Netflix shares.
10/08/19
PIPR
10/08/19
NO CHANGE
Target $440
PIPR
Overweight
Netflix loses lead to YouTube in Piper Jaffray teen survey
Piper Jaffray asked 9,500 high school students what percentage of their video consumption time they spend watching Netflix (NFLX), cable TV, Alphabet's (GOOG, GOOGL) YouTube and other over-the-top platforms, analyst Michael Olson tells investors in a research note. Netflix dipped slightly to 35% from 37% in Piper's last survey, ceding its multi-year pole position to YouTube, which leap-frogged to the top with 37%, up from 32% in the spring survey, says Olson. However, he believes Netflix continues to maintain "strong teen mind share" and attributes the position switch with YouTube at least partially to core differences between the content. Overall, fewer teens are indicating that their household subscribes to cable/satellite TV, which lost the most share, down to 12% versus 14% prior, the analyst points out. Olson maintains an Overweight rating on Netflix with a $440 price target.
10/03/19
DBAB
10/03/19
NO CHANGE
Target $1600
DBAB
Buy
Alphabet price target raised to Street-high $1,600 from $1,475 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Alphabet (GOOG) to $1,600 from $1,475 and keeps a Buy rating on the name. The new target is the highest among sell-side analysts, according to Bloomberg. Shares of Alphabet closed Wednesday at $1,176.63. The "inflection" in Google Cloud under CEO Thomas Kurian, combined with improving disclosures, "helps bolster the bull thesis" around Alphabet shares, Walmsley tells investors in a research note. He thinks Google Cloud can compound revenue at 55% between 2018 and 2022, reaching $17B. Further, Google Cloud can contribute an estimated 7% to EBIT in 2022, says Walmsley.
10/14/19
SPHN
10/14/19
NO CHANGE
SPHN
Google App Store ban likely moderate friction for subprime lenders,says Stephens
Stephens analyst Vincent Caintic says that Google's (GOOG; GOOGL) decision to remove apps offering greater than 36% APR loans will likely be a moderate friction for subprime lenders in his coverage, particularly those with an online focus such as Curo Group (CURO), Elevate Credit (ELVT) and Enova International (ENVA). Overall, the analyst expects some slowdown as a result of app removal. Meanwhile, Caintic notes that the group that pushed for the app removal said it plans to push for a similar ban from Apple (AAPL).
GOOG Alphabet
$1,218.23

4.37 (0.36%)

WMT Walmart
$119.12

-1.12 (-0.93%)

10/14/19
MSCO
10/14/19
NO CHANGE
Target $125
MSCO
Overweight
PhonePe spin could create clearer path to value for Walmart, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman noted that India's Economic Times recently reported that PhonePe could be spun out from Flipkart, with the article claiming that Walmart would keep the 77% stake in the company it currently holds via its existing stake in Flipkart. He values PhonePe at $7B in his base case and $20B in his bull case, believes it to be an underappreciated asset within Walmart and thinks a spin could help to unlock value, Gutman tells investors. He keeps an Overweight rating and $125 price target on Walmart shares.
10/11/19
MSCO
10/11/19
NO CHANGE
Target $125
MSCO
Overweight
Walmart U.S. CEO transition should be smooth, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman said the departure of Greg Foran from Walmart to accept the CEO job at Air New Zealand and the promotion of John Furner to become President and CEO of Walmart U.S. were unexpected, but "make sense given the circumstances." Furner has spent over 25 years in various roles and divisions of Walmart, noted Gutman, who expects "a relatively smooth handoff" and has confidence the transition "should be a clean one." He also said investors may be concerned Foran's departure could be read as a sign that Walmart U.S. is operating at peak performance, but Gutman does not believe this is the case and sees room for improvement that Furner's specific skills should help address. He keeps an Overweight rating on Walmart shares.
09/23/19
BARD
09/23/19
NO CHANGE
Target $130
BARD
Outperform
Walmart price target raised to $130 from $120 at Baird
Baird analyst Peter Benedict raised his price target on Walmart to $130 from $120 following meetings with management. The meetings were upbeat as efforts to transform its core retail capabilities and culture are gaining traction with consumers which is fueling an evolving market perception of the company. Benedict reiterated his Outperform rating on Walmart shares.
09/30/19
WELS
09/30/19
NO CHANGE
Target $30
WELS
Outperform
National Vision price target lowered to $30 from $37 at Wells Fargo
Wells Fargo analyst Zachary Fadem lowered his price target for National Vision (EYE) to $30 from $37 giving near-term overhangs. The analyst also notes that sentiment is "increasingly poor," but margin improvement offers a chance at redemption. While investor sentiment around Walmart (WMT) has shifted from an opportunity to an overhang, Fadem believes shares now price a worst case scenario that he views unlikely near-term. He reiterates an Outperform rating on National Vision's stock.

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$53.80

0.3 (0.56%)

, AAPL

Apple

$265.73

3.07 (1.17%)

10:01
11/16/19
11/16
10:01
11/16/19
10:01
Periodicals
Berkshire Hathaway inactive with record cash hoard, Barron's says »

Berkshire Hathaway…

WFC

Wells Fargo

$53.80

0.3 (0.56%)

AAPL

Apple

$265.73

3.07 (1.17%)

OXY

Occidental Petroleum

$38.94

1.18 (3.13%)

BRK.B

Berkshire Hathaway

$219.74

0.38 (0.17%)

BRK.A

Berkshire Hathaway

$329,361.11

266.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

DIS

Disney

$144.63

-2.56 (-1.74%)

09:43
11/16/19
11/16
09:43
11/16/19
09:43
Periodicals
Disney+ may not be able to hold onto huge number of subs, Barron's says »

While Disney's (DIS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$112.11

2.9 (2.66%)

09:27
11/16/19
11/16
09:27
11/16/19
09:27
Periodicals
Medtronic shares 'could rise even more,' Barron's says »

Barron's recommended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BR

Broadridge

$119.80

0.485 (0.41%)

09:18
11/16/19
11/16
09:18
11/16/19
09:18
Periodicals
Broadridge a defensive name that can withstand slowdown, Barron's says »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$193.95

-0.02 (-0.01%)

, MDT

Medtronic

$112.11

2.9 (2.66%)

09:07
11/16/19
11/16
09:07
11/16/19
09:07
Periodicals
Barron's suggests dividend stocks for retirement savers »

In this week's…

MCD

McDonald's

$193.95

-0.02 (-0.01%)

MDT

Medtronic

$112.11

2.9 (2.66%)

KO

Coca-Cola

$52.67

0.03 (0.06%)

PRU

Prudential

$93.61

0.82 (0.88%)

SYF

Synchrony

$37.05

0.34 (0.93%)

KEY

KeyCorp

$18.96

0.1 (0.53%)

T

AT&T

$39.49

0.53 (1.36%)

AMGN

Amgen

$220.84

2.29 (1.05%)

CSCO

Cisco

$45.10

0.18 (0.40%)

RCL

Royal Caribbean

$117.91

2.69 (2.33%)

MRK

Merck

$84.89

0.33 (0.39%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

JPM

JPMorgan

$129.51

0.83 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 02

    Dec

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 14

    Jan

  • 21

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 14

    Mar

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

, MSFT

Microsoft

$149.95

1.89 (1.28%)

08:54
11/16/19
11/16
08:54
11/16/19
08:54
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

AAPL

Apple

$265.73

3.07 (1.17%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

THC

Tenet

$30.55

1.08 (3.66%)

GM

General Motors

$36.87

0.07 (0.19%)

FCAU

Fiat Chrysler

$16.02

0.04 (0.25%)

TM

Toyota

$144.29

1.16 (0.81%)

F

Ford

$8.96

0.16 (1.82%)

HMC

Honda

$28.99

0.155 (0.54%)

VWAGY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 04

    Feb

  • 06

    Feb

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

04:55
11/16/19
11/16
04:55
11/16/19
04:55
Conference/Events
Roth Capital pharmaceuticals analysts to hold a luncheon »

Analysts host Dr. John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

CVET

Covetrus

$14.93

1.44 (10.67%)

18:41
11/15/19
11/15
18:41
11/15/19
18:41
Hot Stocks
Covetrus CEO: We're a leader in the humanization of pets »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.54

-0.93 (-2.05%)

18:02
11/15/19
11/15
18:02
11/15/19
18:02
Hot Stocks
Viacom extends cable deal for 'The Office' through 2025 »

Viacom (VIA) announced…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.54

-0.93 (-2.05%)

VIAB

Viacom

$23.07

0.59 (2.62%)

VIA

Viacom

$26.59

1.28 (5.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CWK

Cushman & Wakefield

$19.10

0.1 (0.53%)

17:48
11/15/19
11/15
17:48
11/15/19
17:48
Hot Stocks
Cushman & Wakefield CEO sells 84.6K share of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LMT

Lockheed Martin

$393.52

3.305 (0.85%)

17:39
11/15/19
11/15
17:39
11/15/19
17:39
Hot Stocks
Lockheed Martin awarded maximum $3.33B Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESCA

Escalade

$10.90

-0.09 (-0.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Escalade CEO Fetherman to retire »

Escalade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.96

0.1 (0.78%)

, ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Eldorado, Caesars stockholders approve Eldorado acquisition of Caesars »

Eldorado Resorts (ERI)…

CZR

Caesars

$12.96

0.1 (0.78%)

ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11
Hot Stocks
Fabrinet President Gill sells 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEUM

Pareteum

$0.38

-0.0209 (-5.21%)

17:05
11/15/19
11/15
17:05
11/15/19
17:05
Hot Stocks
Pareteum receives noncompliance notice from Nasdaq »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

Hexo

$1.78

-0.1 (-5.32%)

17:00
11/15/19
11/15
17:00
11/15/19
17:00
Hot Stocks
Hexo was cannabis was being grown in unlicensed space at Niagara site »

HEXO Corp provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$220.84

2.29 (1.05%)

, CELG

Celgene

$110.02

-0.01 (-0.01%)

16:57
11/15/19
11/15
16:57
11/15/19
16:57
Hot Stocks
Bristol-Myers gets FTC clearance for Celgene acquisition »

Bristol-Myers Squibb…

AMGN

Amgen

$220.84

2.29 (1.05%)

CELG

Celgene

$110.02

-0.01 (-0.01%)

BMY

Bristol-Myers

$58.61

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

RAVE

Rave Restaurant

$1.44

-0.79 (-35.43%)

16:47
11/15/19
11/15
16:47
11/15/19
16:47
Hot Stocks
BBRC Asset Management reports 6.6% passive stake in Rave Restaurant »

BBRC Asset Management …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$0.89

-0.0521 (-5.52%)

16:46
11/15/19
11/15
16:46
11/15/19
16:46
Hot Stocks
Chaparral Energy receives continued listing standard notice from NYSE »

Chaparral Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

CI

Cigna

$196.08

6.41 (3.38%)

, CNC

Centene

$57.57

2.91 (5.32%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks closed out the…

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

NVDA

Nvidia

$204.12

-5.76 (-2.74%)

AMZN

Amazon.com

$1,739.33

-15.38 (-0.88%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

UAA

Under Armour

$17.78

0.65 (3.79%)

UA

Under Armour

$15.97

0.41 (2.64%)

AMRN

Amarin

$23.99

2.5 (11.63%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

GOOG

Alphabet

$1,334.01

21.82 (1.66%)

GOOGL

Alphabet Class A

$1,333.33

23.54 (1.80%)

ORCL

Oracle

$56.43

0.33 (0.59%)

RH

RH

$188.73

13.535 (7.73%)

QGEN

Qiagen

$40.56

3.255 (8.73%)

FTCH

Farfetch

$9.66

2.17 (28.97%)

THC

Tenet

$30.55

1.08 (3.66%)

TORC

resTORbio

$1.10

-6.83 (-86.13%)

ACB

Aurora Cannabis

$2.72

-0.57 (-17.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 28

    Dec

  • 06

    Jan

  • 21

    Jan

  • 06

    Feb

NYT

New York Times

$31.60

0.44 (1.41%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
New York Times CEO sells 66,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEX

Wex

$200.52

4.61 (2.35%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
Wex director Morris sells 3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.